Winton Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q1
$70.5M Buy
1,197,911
+77,969
+7% +$4.35M 0.49% 41
2013
Q4
$57.1M Buy
1,119,942
+232,719
+26% +$11.7M 0.51% 35
2013
Q3
$44.7M Sell
887,223
-218,350
-20% -$11.4M 0.54% 33
2013
Q2
$54.3M Buy
+1,105,573
New +$60.2M 0.66% 17

Other funds holding LLY

Winton Capital Management's LLY Position: Q1 2014 in Review

Winton Capital Management increased its Eli Lilly (LLY) stake by 7% in Q1 2014, buying an estimated $4.35M and bringing the position to 1,197,911 shares worth $70.5M. The position accounts for 0.49% of the portfolio, ranked #41.

Winton Capital Management first reported a position in LLY in Q2 2013 and has held it in 4 quarters since. 1,026 funds tracked by Wall St. Rank hold LLY as of Q1 2014.

  • Winton Capital Management held 1,197,911 shares of Eli Lilly worth $70.5M as of Q1 2014.
  • Winton Capital Management bought 77,969 Eli Lilly shares in Q1 2014, an estimated $4.35M.
  • Eli Lilly made up 0.49% of Winton Capital Management's portfolio in Q1 2014, its #41 holding.
  • Winton Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 4 quarters since.
  • 1,026 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2014.

Based on Winton Capital Management's 13F filing for Q1 2014, filed 1 May 2014.